Loading...
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
BACKGROUND: The ‘Prediction Of Survival in Advanced Sorafenib‐treated HCC’ (PROSASH) model addressed the heterogeneous survival of patients with hepatocellular carcinoma (HCC) treated with sorafenib in clinical trials but requires validation in daily clinical practice. This study aimed to validate,...
Na minha lista:
| Udgivet i: | Liver Int |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6973249/ https://ncbi.nlm.nih.gov/pubmed/31579990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14270 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|